"SRS is a leading society in our industry, and we share a common vision to support research and education efforts to advance care for all patients with spinal deformities," said
As part of the SRS Annual Meeting, NuVasive will host a workshop titled "Over a decade of MAGEC®: outcomes and efficacy through data and real-world experiences" presented by Professor
NuVasive has partnered with SRS, the premier international society aimed at fostering optimal care for all patients with spinal deformities, since 2007. The Company's ongoing double diamond sponsorship supports clinical workshops, hands-on educational courses, and fellowship and grants for more than 1,500 of the world's leading spine surgeons, researchers, physician assistants, and orthotists who are involved in the research and treatment of spinal deformities.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-as-double-diamond-sponsor-at-scoliosis-research-society-annual-meeting-301621503.html
Investor contact: Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, email@example.com; Media contact: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, firstname.lastname@example.org